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In isolation, both weak isomorphous/anomalous difference
signals from heavy-atom derivatization and phases from
partial molecular-replacement solutions for a subset of the
asymmetric unit often fall short of producing interpretable
electron-density maps. Phases generated from very partial
molecular-replacement models (if generated carefully) can be
used to reliably locate heavy-atom sites, even if the signal
is not sufﬁciently strong to allow robust ﬁnding of the sites
using Patterson interpretation or direct methods. Additional
advantages are that using molecular-replacement phases to
deﬁne the heavy-atom substructure avoids the need for sub-
sequent hand determination and/or origin-choice reconcilia-
tion and that the partial model can be used to aid the mask
determination during solvent ﬂattening. Two case studies are
presented in which it was only by combining experimental and
molecular-replacement phasing approaches that the crystal
structures could be determined.
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1. General principles and computer programs used
When we learn how to determine crystal structures, we
traditionally think of there being two major routes to phase
determination: ‘experimental’ or ‘molecular replacement’.
However, in a minority of cases we can get stuck when,
whatever is performed in data collection and analysis, the
quality of the maps obtained from either of these processes is
not sufﬁcient to generate an ‘interpretable’ map. Here, we
present two case studies in which it was only by combining
both phasing approaches (and a certain degree of intransi-
gence) that the structures were determined. Combining
experimental phases in reﬁnement is by no means a new
concept: for a review of the advantages that phase combina-
tion brings to macromolecular reﬁnement, see Pannu et al.
(1998), Adams et al. (2009) and references therein. This article
does not set out to be a tutorial in either experimental phasing
or molecular-replacement theories or practical methodologies;
there are many good articles that already ﬁll this ecological
niche (e.g. Dodson, 2003, 2008; Dauter et al., 2002; Perrakis et
al., 2001). Rather, we hope that this small contribution will ﬁt
in the by now time-honoured tradition of case-study papers
in issues of Acta Crystallographica Section D devoted to the
proceedings of the CCP4 Study Weekend (Sanders et al., 2001;
Stewart et al., 2008; Esnouf et al., 2006; Cowan-Jacob et al.,
2007; Jenni & Ban, 2009; Rudenko et al., 2003; Calderone,
2004). We also do not wish to seek to claim that the methods
we present are the only ones by which these structures could
have been determined, but they are the way that we deter-
mined them. Nor have we performed a close comparison of
whether different computer programs could have been used to
accomplish the various computational steps: these are realcase studies and we present the results obtained from the
software we used and our rationale for choosing that software,
bearing in mind that at least part of any rationale for software
choice is always familiarity. The ﬂexibility of the SHARP
(Vonrhein et al., 2007) experimental phasing suite and in
particular the ease with which an external source of phases can
be input to allow heavy-atom ﬁnding on a common origin
to another set of phases, together with incorporation of these
‘external’ phases in the reﬁnement of the heavy-atom model,
led us to use SHARP for our experimental phase determina-
tion. Similarly, it has previously been demonstrated that where
molecular-replacement models are highly partial (i.e. less
than 60% complete), modelling the ‘missing atoms’ as part
of reﬁnement signiﬁcantly improves the quality of the maps
obtained (Blanc et al., 2004). In this way, BUSTER-TNT has
the advantage that its low-resolution Fcalc can include a con-
tribution from the part of the structure that is ordered but is
yet to be modelled (the ‘missing atoms’); this in turn makes the
scaling more accurate and decreases the model bias that is
normally introduced by the reﬁnement of partial structure
parameters against data that contain scattering from the
entirety of the asymmetric unit. In our hands, even at the
earliest stages of reﬁnement with models constituting only one
third of the structure the use of missing-atom modelling in
BUSTER-TNT was viable if phase-combined maps were used
to deﬁne the missing atoms’ prior distribution. The latter was
accomplished by using a combined BUSTER-TNT/SHARP
solvent-ﬂattened map (the phases were combined in SHARP
and solvent ﬂattening was carried out with SOLOMON
launched from within the SUSHI interface) to deﬁne the
missing-atoms envelope during reﬁnement.
2. Case studies
Both case studies presented here involve the determination
of structures that include domains of the human complement
regulator factor H (fH). fH is a classic ‘beads-on-a-string’
molecule consisting of 20 sequential short consensus repeat
domains (SCRs) connected by linker sequences of between
one and ﬁve residues. fH is an important component of the
innate immune system that acts to regulate the destructive
power of the complement system and prevent harm to our
own cells. fH acts both by dissociation of a cell-surface
molecule (C3bBb; the so-called ‘decay-accelerating’ activity)
and also by assisting the direct cleavage of the same molecule
by another enzyme, complement factor I (the so-called ‘co-
factor’ activity). These activities are carried out via a variety of
protein–protein and protein–carbohydrate interactions that
occur at different sites along the extended fH molecule. Prior
to the work on the fH constructs reviewed here, the structures
of many SCR domains were known (both from fH and from
other proteins) and some information was available about the
overall fH architecture from both electron microscopy and
small-angle X-ray scattering, but there was no atomic struc-
tural information about the sixth to eighth SCR domains,
which are involved in various interesting biological roles. SCR
domains are about 60 residues long and contain two conserved
disulﬁde bridges and a conserved tryptophan. There are about
30 independent atomic structures of SCRs available in the
Protein Data Bank (Soares et al., 2005). Therefore, when
initiating the factor H crystallographic projects described here,
at least two obvious modes of obtaining phasing information
presented themselves: ﬁrstly, molecular replacement would
seem an entirely reasonable approach and, secondly, in the
event of failure of that approach sulfur-SAD could potentially
be used.
2.1. Case study 1: the structure of SCRs 6, 7 and 8 from the
complement regulator factor H
Although the structures of several fH SCR domains were
already known, we were interested in the structure and
arrangement of domains in the region of SCR domain 7, since
this region is implicated in recognition of surface glycosami-
noglycans, thus conferring on fH the selectivity that enables it
to protect self-tissues against complement-mediated lysis. In
order to obtain structural insight into the fH–glycosamino-
glycan recognition event, crystals were grown of a three SCR-
domain construct comprising domains 6, 7 and 8 (fH678)
in complex with sucrose octasulfate (SOS; Prosser, Johnson,
Roversi, Herbert et al., 2007), a highly sulfated analogue of
glycosaminoglycans.
Crystals of fH678–SOS were obtained and native data were
collected to 2.4 A ˚ resolution; the crystals belonged to space
group C2221 and had a likely content of one copy of fH per
asymmetric unit (Prosser, Johnson, Roversi, Clark et al., 2007).
We then sought to use all possible SCR domains from the
PDB to determine the structure by three different molecular-
replacement protocols: three sequential searches for single
SCR search models, a search for a pair of SCR domains
followed by an additional single one or a single search for a
triple SCR-domain search model. The molecular-replacement
computer programs used were MOLREP, Phaser and AMoRe
from CCP4. Various modiﬁcations of the models, including the
use of CHAINSAW (Stein, 2008), reducing to the backbone
and forming ensembles, were tried. None of these attempts
provedsuccessful.Thiswasrationalizedasarisingfromthefact
that whilst it was clear that the three domains we were
searching for were SCR domains (each with a pair of
conserved disulﬁdes and a buried tryptophan), the level of
sequence identity was low (20–30%). When different SCR
models are overlaid, it is clear that these domains pack a lot of
structural variation into a small and fairly constrained struc-
ture. SCR interdomain angles also vary widely and cannot be
predicted. These orthorhombic crystals suffered rapid radia-
tion damage, thus hindering attempts at phasing by sulfur-
SAD (which needs high-redundancy data sets, preferably
collected from a single crystal) or phasing by radiation
damage-induced phasing (RIP; Ravelli et al., 2003) (which
needs a relatively radiation-damage-free data set before the
non-isomorphism is introduced by a heavy X-ray dose and still
requires measurable diffraction from the same crystal after-
wards). As FH678 contains two methionines (one in SCR
domain 6 and one in SCR domain 7), SeMet labelling of the
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collected (for details of data quality, see Prosser, Johnson,
Roversi, Clark et al., 2007) and autoSHARP–SHELXD could
interpret both the anomalous and the isomorphous difference
Patterson maps with a model containing two Se atoms.
SHARP was used to reﬁne the heavy-atom model against a
2.4 A ˚ resolution native data set and a three-wavelength 2.5 A ˚
resolution SeMet MAD data set and SOLOMON was used to
solvent-ﬂatten the resultant phases, but the correct hand could
not be distinguished. The Patterson peak heights and the
heavy-atom parameters reﬁned for these two sites in SHARP
suggested that one of the methionines was signiﬁcantly more
ordered than the other and even the more ordered methionine
was undergoing a large thermal motion: the SHARP B factor
for one Se reﬁned to around 100 A ˚ 2 and the B factor for the
other Se reﬁned to around 170 A ˚ 2. These B-factor values were
obtained consistently against isomorphous and anomalous
differences from a number of different SeMet MAD data sets
and irrespective of the treatment of heavy-atom site occu-
pancies during the reﬁnement protocol; both letting individual
Se occupancies vary while keeping f0 and f00 at the experi-
mentally measured values and keeping the occupancies ﬁxed
to unity while reﬁning f0 and f00 instead produced the same
result. The ﬁnal reﬁned B factors for the S atoms of these Met
residues in the deposited crystal structure are 52 and 90 A ˚ 2
(the average B factor for the side chain was 50 A ˚ 2). The lack of
hand discrimination power of this set of experimental phases
was therefore not unexpected, since attempting to phase a
186-residue structure with essentially one poorly ordered Se
atom was rather beyond the realms of the possible. Attempts
to use heavy-atom soaks to generate additional phasing
information also failed.
At this point new phase information was needed and it was
provided in the form of the structure of SCR 7 (hereafter
known as fH7), which was determined by Paul Barlow and
colleagues using NMR (Herbert et al., 2007). A single copy of
a search model from the NMR ensemble could unambiguously
be found using each of the molecular-replacement programs:
the MR hit (as became obvious with hindsight after structure
completion) was always to the fH7-domain placement and
repeating the search with the same fH7 model (or any of the
other SCR domains from the PDB in the presence of the fH7
ﬁrst partial model) did not reveal the position and orientations
of the ﬂanking SCR domains. Reﬁnement of the fH7 model
(consisting of less than a third of the structure) against the
fH678–SOS data using BUSTER-TNT led to maps which were
not readily interpretable outside of the modelled domain.
At this point we were therefore in possession of two sets of
poor phasesand so it became an obvious strategy to attempt to
combine these phase distributions to generate improved phase
estimates (Read, 1986). Various methods for combining the
experimental and molecular-replacement phases were con-
sidered, but for ease of resolution of hand/origin issues and
also to help the conditioning of the heavy-atom reﬁnement
we decided to use the DM solvent-ﬂattened BUSTER-TNT
phases as input to SHARP and to use them for heavy-atom
location, heavy-atom reﬁnement and to generate the ﬁnal
phase distributions. These phases were good enough to con-
ﬁrm the location of both Se atoms in the isomorphous and
anomalous log-likelihood gradient (LLG) maps in SHARP;
more importantly, reﬁnement of the two-Se heavy-atom model
conditioned by the BUSTER-TNT phases and solvent ﬂat-
tening of the internally combined phase distributions (using
SOLOMON as driven from the SUSHI interface) produced a
new ‘phase-combined and solvent-ﬂattened’ map that began
to show sensible electron density outside the fH7 model and
allowed the building of some residues at the N- and C-termini
of the central domain. It is worth noting the phase combina-
tion with the model phases prior to solvent ﬂattening had
the additional advantage that the solvent-ﬂattening masks
included the parts of structure modelled thus far. Fig. 1 shows
the phase errors between both the uncombined and combined
phases compared with the reference phases generated from
the ﬁnal reﬁned model. Fig. 2 shows the quality of the corre-
sponding maps. Whilst it is clear that the combined phases
were not magically ‘correct’ (and they certainly did not allow
automatic model building), they were sufﬁciently improved
that manual rebuilding could begin. Indeed, we followed a
iterative phasing protocol, each cycle of which comprised
(i) building of a small additional portion of the model, (ii)
reﬁnement in BUSTER-TNT using the solvent-ﬂattened
combined phasesfrom thepreviouscycle todeﬁne themissing-
atoms envelope during reﬁnement and (iii) calculation of a
new set of combined phases within SHARP to help reﬁnement
of the heavy-atom model and guide the solvent ﬂattening of
maps for the next round of model building. This process
eventually allowed the construction of the complete model for
the fH SCR domains 6, 7 and 8 and location of the bound SOS
(Prosser, Johnson, Roversi, Herbert et al., 2007).
2.2. Case study 2: the crystal structure of a complex between
SCR domains 6 and 7 from complement regulator factor H
and the factor H-binding neisserial protein fHbp
The next example will also show the power of phases from
a highly incomplete model to locate and aid reﬁnement of
research papers
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Figure 1
Mean phase error across the resolution range for fH678 phase sets at
various stages of structure solution compared with calculated phases from
the ﬁnal complete model.heavy-atom sites. This example also involves a fragment of the
crystal structure discussed in the previous section: the sixth
and seventh SCR domains of fH were crystallized in complex
with a Neisseria meningitidis protein whose biological function
is to scavenge fH onto the bacterial surface (Schneider et al.,
2009). The neisserial protein fHbp is approximately twice
the size of the two-domain construct fH67 and consists of a
C-terminal half (the NMR structure of which was available;
Cantini et al., 2006) and an N-terminal half of unknown
structure. As such, this project seemed another obvious case
where molecular replacement was likely to be successful: one
third of the structure was known from a crystal structure
(Prosser, Johnson, Roversi, Herbert et al., 2007), one third was
known from an NMR solution structure (Cantini et al., 2006)
and the ﬁnal third was unknown. The crystals belonged to
space group C2 and the unit-cell volume (Matthews, 1968) and
the self-rotation function suggested that there were likely to
be three copies of the complex per asymmetric unit. Initially,
three copies of the fH domains could be located using each of
the abovementioned CCP4 molecular-replacement programs;
however, despite extensive searching
with the NMR ensemble and models,
the known portion of the fHbp structure
could not be found. Even with missing-
atom modelling switched on in
BUSTER-TNT and with threefold
averaging applied, it was not surprising
that reﬁnement of the fH domains alone
did not yield an interpretable map for
the missing fHbp components, as the
partial structure only accounted for one
third of the asymmetric unit.
Pt- and Hg-soaked crystals yielded
diffraction data sets to a resolution of
3.2 A ˚ ; a SAD experiment collected at a
wavelength of 1.8 A ˚ gave a 3 A ˚ resolu-
tion 28-fold redundant data set to
exploit the anomalous signal from the
33 S atoms in the asymmetric unit. None
of the data/signals were of sufﬁcient
quality to allow heavy-atom ﬁnding
de novo, but using the partial model
BUSTER-TNT phases in SHARP
allowed the detection of six Pt sites and
one Hg site, and also conﬁrmed (with
peaks higher than 3 in SHARP
anomalous LLG residual maps) the
location of 11 of the 12 disulﬁdes
present in the fH portion of the asym-
metric unit, providing a good indepen-
dent corroboration of the molecular-
replacement solution. SOLOMON
solvent ﬂattening and DM threefold
averaging produced a map in which the
majority of the fHbp C-terminal domain
could be traced. Once this model had
been reﬁned (the model now being
about two-thirds complete), additional
S sites added and the phases again
combined, the rest of fHbp could be
traced: it turned out that the N-terminal
domain was also a -barrel, although
differing in topology from the C-term-
inal one. At the end, 31 of the 33 sulfur
sites were visible in the anomalous LLG
maps of the long-wavelength SAD data
set. Fig. 3 shows the mean phase errors
research papers
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Figure 2
Electron-density maps calculated at various stages of the fH678 structure solution with the ﬁnal
coordinates displayed as stick models. The inset shows a close-up of a typical portion of the map in a
region for which no molecular model existed at the point of calculating the map. (a)ASOLOMON
solvent-ﬂattened map derived from SHARP phase distributions generated from SeMet anomalous
data. (b) BUSTER-TNT phases generated by reﬁning fH7 against the fH678 data with missing
atoms modelled. (c) SOLOMON solvent-ﬂattened map using SHARP phase distributions
generated from SeMet anomalous data in which BUSTER-TNT phase distributions (as in b) were
used within the SHARP reﬁnement and for calculation of SHARP output phase distributions.of the phases derived from the third of the model before and
after combination with the heavy-atom phases from the sites
located using the same partial model. Post factum comparison
of the ﬁnal structure of fHbp with the earlier NMR structure
of the C-terminal barrel suggests that molecular replacement
failed owing to small but signiﬁcant distortions of the -
strands: the strands in the NMR structure could not all be
aligned along the lengths of the crystal structure strands, so
that any placement that aligned any one strand misplaced the
others.
3. Conclusions
Using phases generated from very partial molecular-replace-
ment models (if generated carefully) can reliably locate heavy-
atom sites using either isomorphous or anomalous difference
signals (even if the signal is not sufﬁciently strong to allow
robust ﬁnding of the sites using Patterson interpretation or
direct methods), with the additional advantage that using
molecular-replacement phases to deﬁne the heavy-atom sub-
structure avoids the need for subsequent hand determination
and/or origin-choice reconciliation. Anomalous signal from
disulﬁdes can also be used as an independent check that a
model placement is correct in situations where reﬁnement
statistics are ambiguous, as is generally the case with very
partial models. By continuously recombining phases derived
from reﬁnement of the rebuilt structure with the experimental
phasing information, potential problems of bias may be alle-
viated, so that rapid progress towards the ﬁnal structure can
be made. We have often found that trivial additions to an
incomplete structure (e.g. of the order of ten residues added
when 200 or more are still missing) can improve the phase
estimates and hence the maps well enough to allow further
rebuilding. Such an incremental approach can turn an appar-
ently hopeless situation into one in which structures can be
completed.
However, there is one small caveat: the approaches detailed
here seemed at the time to be the most efﬁcient way to
complete structure determination. However, a balance should
always be struck between these relatively time-intensive
approaches and the potential pain/gain of going back to the
laboratory to try and obtain different crystals or novel phasing
information of some sort. Nevertheless, as a community, we
should not forget that until recently all structures were built
one residue at a time by hand and often in poor maps, and we
can still do it (if we have to)!
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